Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|17|18|1794-1807
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.17, Iss.18, 2011-06, pp. : 1794-1807
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design, Vol. 23, Iss. 11, 2017-05 ,pp. :
Access to resources
Recommend
Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design, Vol. 17, Iss. 18, 2011-06 ,pp. :
Cardiac resynchronisation therapy worth it in heart failure
Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. :
Cardiac Resynchronization Therapy for Heart Failure: Here to Stay
Heart Drug, Vol. 3, Iss. 3, 2003-11 ,pp. :
By Sentex Emmanuelle Wang Xi Liu Xueliang Lukas Anton Dhalla Naranjan S.
Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 2, 2006-02 ,pp. :